![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 10
Zeitschriftenartikel
Hayden, P. J.; Roddie, C.; Bader, P.; Basak, G. W.; Bonig, H.; Bonini, C.; Chabannon, C.; Ciceri, F.; Corbacioglu, S.; Ellard, R.; Sanchez-Guijo, F.; Jaeger, U.; Hildebrandt, M.; Hudecek, M.; Kersten, M. J.; Koehl, U.; Kuball, J.; Mielke, S.; Mohty, M.; Murray, J.; Nagler, A.; Rees, J.; Rioufol, C.; Saccardi, R.; Snowden, J. A.; Styczynski, J.; Subklewe, M.; Thieblemont, C.; Topp, M.; Ispizua, A. U.; Chen, D.; Vrhovac, R.; Gribben, J. G.; Kroeger, N.; Einsele, H. und Yakoub-Agha, I
(2022):
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).
In: Annals of Oncology, Bd. 33, Nr. 3: S. 259-275
Nasso, D.; Labopin, M.; Ruggeri, A.; Ciceri, F.; Lint, M. T. van; Arcese, W.; Tischer, J.; Blaise, D.; Ehninger, G.; Koc, Y.; Santarone, S.; Bruno, B.; Huang, X.-J.; Savani, B. N.; Mohty, M. und Nagler, A.
(2017):
Impact of Conditioning Regimen on Outcomes of T-Replete Haplo-Identical Transplantation for Patients Over 45 Years-Old with AML: A Study On Behalf Of the Acute Leukemia Working Party of the EBMT.
In: Haematologica, Bd. 102: S. 132
Vrhovac, R.; Labopin, M.; Ciceri, F.; Finke, J.; Holler, E.; Tischer, J.; Lioure, B.; Gribben, J.; Kanz, L.; Blaise, D.; Dreger, P.; Held, G.; Arnold, R.; Nagler, A. und Mohty, M.
(2016):
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes.
In: Bone Marrow Transplantation, Bd. 51, Nr. 2: S. 186-193
Tsirigotis, P.; Byrne, M.; Schmid, C.; Baron, F.; Ciceri, F.; Esteve, J.; Gorin, N. C.; Giebel, S.; Mohty, M.; Savani, B. N. und Nagler, A.
(2016):
Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT.
In: Bone Marrow Transplantation, Bd. 51, Nr. 11: S. 1431-1438
Baron, F.; Ruggeri, A.; Beohou, E.; Labopin, M.; Sanz, G.; Milpied, N.; Michallet, M.; Socie, G.; Blaise, D.; Sierra, J.; Cornelissen, J.; Mohty, M.; Schmid, C.; Giebel, S.; Gorin, N. C.; Esteve, J.; Ciceri, F.; Savani, B.; Gluckman, E. und Nagler, A.
(2016):
Impact of dose intensity on unrelated cord blood transplantation outcomes in adults patients with acute leukemia: A Report from Eurocord, the ALWP and the Cord Blood Committee of the CTIWP of the EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S278-S279
Brissot, E.; Labopin, M.; Ciceri, F.; Bornhäuser, M.; Tischer, J.; Stelljes, M.; Koc, Y.; Stuhler, G.; Fanin, R.; Ganser, A.; Glass, B.; Mohty, M. und Nagler, A.
(2016):
Comparison of haplo-identical versus unrelated allogeneic stem cell transplantation for acute myeloid leukemia with active disease: A report of 1578 patients from Acute Leukemia Working Party of EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S65-S65
Lorentino, F.; Ciceri, F.; Labopin, M.; Ruggeri, A.; Guelbas, Z.; Koc, Y.; Arcese, W.; Bruno, B.; Tischer, J.; Lint, M. T. van; Blaise, D.; Messina, G.; Bornhaeuser, M.; Fleischhauer, K.; Beelen, D. W.; Nagler, A. und Mohty, M.
(2016):
HLA disparities on unshared haplotype influence outcomes of unmanipulated haploidentical hematopoietic stem cell transplantation (HaploSCT): A Study from the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation (EBMT).
In: Bone Marrow Transplantation, Bd. 51:
S28-S29
Robin, M.; Porcher, R.; Lint, M. T. van; Ciceri, F.; Tisher, J.; Sanz, J.; Platzbecker, U.; Biezen, A. van; Kosker, L.; Blaise, D.; Velardi, A.; Peterson, E.; Stuhler, G.; Mufti, G.; Koc, Y.; Bethge, W.; Michallet, M.; Vigouroux, S.; Koenecke, C.; Beelen, D.; Yacoug-Agha, I.; Vitek, A.; Arcese, W.; Witte, T. de und Kroeger, N.
(2016):
Comparison of outcome after haplo-identical, HLA-mismatched unrelated donor and unrelated cord blood transplantation in patients with myelodysplastic syndrome (MDS) and secondary acute myeloblastic leukemia (sAML): an EBMT study.
In: Bone Marrow Transplantation, Bd. 51:
S73-S73
Santoro, N.; Labopin, M.; Ruggeri, A.; Bacigalupo, A.; Ciceri, F.; Guelbas, Z.; Koc, Y.; Arcese, W.; Wu, D.; Huang, H.; Afanasyev, B.; Tischer, J.; Ozdogu, H.; Giebel, S.; Mothy, M. und Nagler, A.
(2016):
Unmanipulated haploidentical stem cell transplantation in adults with Acute Lymphoblastic Leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S2-S2
Gorkom, G. van; Gelder, M. van; Ziagkos, D.; Koster, L.; Koc, Y.; Lint, M. van; Ciceri, F.; Selleslag, D.; Blaise, D.; Foa, R.; Beelen, D.; Corradini, P.; Moreno, C.; Carlson, K.; Solano, C.; Müller, L. P.; Castagna, L.; Tischer, J.; Hilgendorf, I.; Hallek, M.; Bittenbring, J.; Theobald, M.; Schetelig, J. und Kroeger, N.
(2016):
Outcomes of mismatched related allogeneic stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S293-S294